Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 28, 2016
Pharmacy Choice - News - Over-the-Counter Drugs - September 28, 2016

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 33     Next >>     Go To Page:

9/28/16 - Commentary: OTC Hearing Devices Could Make Hearing Worse
In this commentary post on Hearing Review's blog, ASHA President Jaynee Handelsman, PhD, CCC-A, explains why recommendations by the National Academy of Sciences and PCAST are off the mark, and could lead to increased problems in hearing health.
9/28/16 - ESA Medical Announces Availability of the Infrared Heating Device for Pain Management
Huntingdon Valley, PA 09/28/2016 Technological advancements in the medical field have rendered the availability of new pain management solutions with the development of quality electrotherapy devices. The Infrared Heating Device is cleared by the Food and Drug Administration for over-the-counter sale and is certified by UL as a safe product.
9/28/16 - Morning After, a New FDA-Approved Emergency Contraceptive Offered by Rapha Pharmaceuticals, is Now Available at All Fred`s Pharmacy - OTC & No Prescription Needed. [UMCI News]
-The U.S. Food and Drug Administration has approved the use of Morning After a new brand of emergency contraceptive, as a non-prescription product for all child-bearing women. The FDA has fulfilled its commitment to the court by promptly completing its swift review, approval, and labeling requirements giving way for Rapha Pharmaceuticals to place M
9/28/16 - One Solution To EpiPen Crisis: Repeal Durham-Humphrey OpEd [Eurasia Review]
Posturing politicians on Capitol Hill conducted a hearing a few days ago during which they grilled Heather Bresch, CEO of Mylan N.V., maker of EpiPens. The law passed in 1951, half a century after the FDA was instituted. Even if you believe Congress should keep drugs off the market until the FDA has proven their safety and efficacy, that does
9/28/16 - Pernix Therapeutics Announces Distribution of TREXIMET 10/60 mg (sumatriptan 10mg and naproxen sodium 60 mg) Dose For Use in Pediatric Patients
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, today announced the distribution of TREXIMET 10/ 60 mg to wholesalers has begun. The availability of the FDA approved combination of sumatriptan-naproxen could prove to be very helpful for the pediatric population ages 12-17 with acu
9/27/16 - FDA Approves STELARA (Ustekinumab) for Treatment of Adults With Moderately to Severely Active Crohn's Disease
Release date- 26092016- Horsham, Pa- Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration has approved STELARA for the treatment of moderately to severely active Crohn's disease in adults who have failed or were intolerant to treatment with immunomodulators or corticosteroids but never failed treatment with a tumor necr
9/27/16 - Morning After, a New FDA-Approved Emergency Contraceptive Offered by Rapha Pharmaceuticals, is Now Available at All Fred's Pharmacy - OTC & No Prescription Needed.
The U.S. Food and Drug Administration has approved the use of Morning After? a new brand of emergency contraceptive, as a non-prescription product for all child-bearing women. The FDA has fulfilled its commitment to the court by promptly completing its swift review, approval, and labeling requirements- giving way for Rapha Pharmaceuticals to plac
9/26/16 - Call to appoint one pharmacist for every 50 hospital beds [Daily Star, The (Lebanon)]
According to a press release issued here on Sunday, more than 500 pharmacists and students gathered in College of Pharmacy, Punjab University Old Campus and observed the World Pharmacist Day. A cake was cut by Prof Dr Khalid Hussain and Prof Dr Nadeem Irfan Bokhari, dean and principal, respectively, College of Pharmacy, Punjab University. Pakistan
9/26/16 - FDA Approves STELARA (ustekinumab) For Treatment Of Adults With Moderately To Severely Active Crohn's Disease
Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration has approved STELARA for the treatment of moderately to severely active Crohn's disease in adults who have failed or were intolerant to treatment with immunomodulators or corticosteroids but never failed treatment with a tumor necrosis factor blocker, or who fail
9/26/16 - Gujarat has Evolved into a Major Pharmaceutical Hub in India, Contributing More than 20% to the Sectors National Turnover [Tripoli Post, The (Libya)]
Increasing accessibility and Ease of Doing Business has made Gujarat one of the most preferred destination for investment globally. Leading the way in becoming an inspirational model for pharmaceutical sector, Gujarat has evolved into a hub for major pharmaceutical companies. Pharmaceutical industry is one of the oldest industry in Gujarat, with th
9/26/16 - SERMO Polls Reveal U.S. Doctors Sentiments on Healthcare Issues at the Forefront of Policy Debates
As candidates Donald Trump and Hillary Clinton prepare to face off in their first presidential debate, SERMO, the leading global social network exclusively for physicians, polled its network of U.S. physicians on crucial healthcare issues facing the next administration. 56 percent of physicians believe the government should stop allowing drug compa
9/24/16 - Avail yourselves of pharmacistsservices [Qatar Tribune]
Pharmaceutical Society of Nigeria President, Ahmed Yakasai, has urged Nigerians to avail themselves of the services of pharmacists nationwide. In a message to commemorate this years World Pharmacy Day, he described a pharmacist as an invaluable source of information on medicines and that it is consumers right to tap this huge reserve and potential.
9/24/16 - Endo Internat Soars on New CEO Announcement [Kuwait News Agency]
The drugmaker officially named Paul V. Campanelli as president and CEO effective immediately. The company which has its U.S. headquarters in Malvern looked internally for its replacement as 54- year-old Campanelli was the boss at Par Pharmaceutical, a company that Endo bought last year. Endo chairman Roger Kimmel said the board is very happy with t
9/24/16 - Endo names new CEO, stock surges [Cihan News Agency (Turkey)]
Shares of Endo International soared Friday after the drug maker named Paul V. Campanelli as president and CEO effective immediately. The company, with U.S. headquarters in Malvern, said that Rajiv De Silva has stepped down as chief executive officer and a board member. "Given the continued evolution of Endo`s business and Paul`s impressive track r
9/24/16 - How Older People Can Head Off Dangerous Drug Interactions
For example, your kidney and liver may not work as well, which affects how drugs are broken down and leave your body, the FDA said. Sandra Kweder, an FDA medical officer, said in an agency news release. The FDA says these safety tips will help prevent harmful drug interactions or side effects:.
9/24/16 - MonoSol Rx Responds to Civil Complaint Filed by States Attorneys General [FARS News Agency]
-MonoSol Rx develops and manufactures FDA- approved pharmaceutical film products. I think it is important to add that Suboxone sublingual film is a product which has saved countless lives since its approval by the FDA in 2010.. MonoSol Rx`s leadership in film drug delivery is supported by strong IP protection, a robust pipeline of prescription drug
9/24/16 - Pfizer Inc. vs. Johnson & Johnson [Cihan News Agency (Turkey)]
Among the top participants in big pharma are Pfizer and Johnson& Johnson, and although J&J`s business has a much larger scope that fully incorporates other products like medical devices and over-the-counter consumer health products, its pharmaceutical exposure has been its big growth driver in recent years. With that in mind, let`s compare Pfizer a
9/23/16 - Bharat Book Bureau: Pharmaceutical Excipients Global Market - Forecast
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability and stability of active substances for formulating final drug dosage forms. The excipients form the major part of any medicinal product and proportion of it when compared to Active Pharmaceutical Agent exceeds two to three fold in any
9/23/16 - Endo names new CEO, stock surges [Philly.com]
Sept. 23 Shares of Endo International soared Friday after the drug maker named Paul V. Campanelli as president and CEO effective immediately. The company, with U.S. headquarters in Malvern, said that Rajiv De Silva has stepped down as chief executive officer and a board member. "The board is very confident that Paul is the right choice to lead E
9/23/16 - FDA CONSUMER HEALTH INFORMATION: Antibacterial Soap? You Can Skip ItUse Plain Soap and Water
According to the U.S. Food and Drug Administration, there isn't enough science to show that over-the-counter antibacterial soaps are better at preventing illness than washing with plain soap and water. After studying the issue, including reviewing available literature and hosting public meetings, in 2013 the FDA issued a proposed rule requiring saf
9/23/16 - FDA issues final rule on safety and effectiveness of antibacterial soaps
By a News Reporter-Staff News Editor at Drug Week The U.S. Food and Drug Administration issued a final rule establishing that over-the-counter consumer antiseptic wash products containing certain active ingredients can no longer be marketed. Companies will no longer be able to market antibacterial washes with these ingredients because manufacture
9/23/16 - Glaxo names Emma Walmsley as new CEO to succeed Andrew Witty [Kuwait News Agency]
GlaxoSmithKline Plc promoted Emma Walmsley to be its new chief executive officer and succeed Andrew Witty when he retires, singling out the UK`s largest drugmaker as the only major global pharmaceutical company led by a woman. She will join the board on Jan 1 and take the helm of the London- based company on March 31, Glaxo said in a statement on T
9/23/16 - HeartBoost and BrainBest, AngioGenesis Labs Liquid Health Supplements, Expand to More than 450 Convenience Stores [Moj News Agency (Iran)]
-AngioGenesis Labs, a leading manufacturer of liquid dietary supplements, has expanded distribution of HeartBoost and BrainBest to more than 450 convenience stores in 5 Southeast states including Louisiana, Mississippi, Florida, Alabama and Texas. AngioGenesis Labs supplements are packaged in easy to consume 2 oz shots. Several key ingredients in..
9/23/16 - KALOBIOS PHARMACEUTICALS INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations.
You should read the following discussion and analysis together with our financial statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10 Q and our Annual Report on Form 10- K for the fiscal year ended December 31, 2015. This Quarterly Report on Form 10- Q contains statements that discuss that discuss f
9/23/16 - MonoSol Rx Responds to Civil Complaint Filed by States Attorneys General
MonoSol Rx develops and manufactures FDA- approved pharmaceutical film products. As a small innovative company with R&D in New Jersey and manufacturing in Indiana, we are proud of our patented technology and the value it has brought to patients and caregivers, said Keith Kendall, CEO of MonoSol Rx. I think it is important to add that Suboxo
Articles(s): 1 - 25 of 33     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415